VCM
ORKA

Voleon Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Voleon Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Sell
3,557
-36,982
-91% -$2.46M 0.01% 656
2026
Q1 		$1.99M Buy
40,539
+16,991
+72% +$590K 0.04% 331
2025
Q4 		$714K Buy
+23,548
New +$656K 0.02% 505

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Voleon Capital Management's ORKA Position: Q2 2026 in Review

Voleon Capital Management reduced its Oruka Therapeutics (ORKA) stake by 91% in Q2 2026, selling an estimated $2.46M and leaving 3,557 shares worth $339K. The position accounts for 0.01% of the portfolio, ranked #656.

Voleon Capital Management first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.99M in Q1 2026. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Voleon Capital Management held 3,557 shares of Oruka Therapeutics worth $339K as of Q2 2026.
  • Voleon Capital Management sold 36,982 Oruka Therapeutics shares in Q2 2026, an estimated $2.46M.
  • Oruka Therapeutics made up 0.01% of Voleon Capital Management's portfolio in Q2 2026, its #656 holding.
  • Voleon Capital Management first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Voleon Capital Management's Oruka Therapeutics position peaked at $1.99M in Q1 2026.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.